Biose Industrie was founded in 1951 under the name Lyocenter Laboratories to specialize in manufacturing bacteria as a drug
The 1940s and 1950s were known as a ‘golden age’ of microbiology, with scientists making major advances in knowledge about bacteria as well as the development of many life-saving antibiotic drugs: penicillin, streptomycin, and tetracycline. After World War II, scientists also wanted to develop drug products that would supply beneficial..Read More
Between 1970 and 1975, the company moved to a new site that still serves its needs decades later
During its first two decades, Biose Industrie served a steady lineup of clients in bugs as drugs industry. The company leadership had the ambition to become the top global CDMO for live biotherapeutic products but knew the organisation would soon outgrow its existing facility located in an isolated area north..Read More
New owners bring increased focus on microbes as drugs
French family takes ownership as company begins its ascent to top global CDMO for live biotherapeutic products Biose Industrie manufactured several types of drugs throughout the 1970s and 1980s, having broad capabilities under the ownership of the Reti Group and then AzkoNobel. But it was under the leadership of its..Read More
Biose Industrie Raises EUR 30M to Strengthen its Position as the Reference CDMO in the Field of Microbiota
Aurillac, July 16, 2020 – Biose Industrie announced today the closing of a €30 million funding round led by Cathay Capital, alongside the company’s management team, banking partners and the Auvergne-Rhône-Alpes region. Thanks to this funding found, Biose Industrie will benefit from Cathay Capital’s support as it accelerates its development..Read More
